ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ICVX Icosavax Inc

15.31
0.00 (0.00%)
Pre Market
Last Updated: 20:00:00
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Icosavax Inc ICVX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 15.31 20:00:00
Open Price Low Price High Price Close Price Prev Close
15.31
more quote information »

Recent News

Date Time Source Heading
4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
3/01/202408:30EDGAR2Form 15-12G - Securities registration termination [Section..
2/21/202416:21EDGAR2Form SC 13D/A - General statement of acquisition of..
2/21/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
2/20/202419:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202419:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202419:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202419:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202419:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202419:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202419:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202408:46EDGAR2Form S-8 POS - Securities to be offered to employees in..
2/20/202408:43EDGAR2Form POS AM - Post-Effective amendments for registration..
2/20/202408:42EDGAR2Form 8-K - Current report
2/20/202408:32EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
2/02/202419:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/01/202414:25PRNUSKuehn Law Encourages ICVX, CSTR, AVRO, and CALB Investors to..
1/23/202418:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202409:04EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
1/12/202411:10PRNUSKuehn Law Encourages PXD, IMGN, HA and ICVX Investors to..
1/05/202419:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202417:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:52EDGAR2Form 144 - Report of proposed sale of securities
1/03/202414:57PRNUSKuehn Law Encourages EGLE, ICVX, RAIN, and AYX Investors to..
12/27/202308:55EDGAR2Form SC 14D9 - Solicitation, recommendation statements
12/22/202318:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/22/202318:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/22/202318:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/22/202318:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/21/202316:42EDGAR2Form 144 - Report of proposed sale of securities
12/21/202316:28EDGAR2Form 144 - Report of proposed sale of securities
12/20/202320:54EDGAR2Form 144 - Report of proposed sale of securities
12/20/202320:50EDGAR2Form 144 - Report of proposed sale of securities
12/20/202320:50EDGAR2Form 144 - Report of proposed sale of securities
12/20/202320:44EDGAR2Form 144 - Report of proposed sale of securities
12/20/202317:05EDGAR2Form SC14D9C - Written communication relating to third party..
12/20/202316:41EDGAR2Form 144 - Report of proposed sale of securities
12/15/202319:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/14/202316:18EDGAR2Form SC14D9C - Written communication relating to third party..
12/13/202316:26EDGAR2Form 144 - Report of proposed sale of securities
12/12/202317:00EDGAR2Form SC14D9C - Written communication relating to third party..
12/12/202316:56EDGAR2Form SC14D9C - Written communication relating to third party..
12/12/202316:12EDGAR2Form 8-K - Current report
12/12/202306:25DJNIcosavax Shares Take Flight on Takeover by AstraZeneca
12/12/202303:02DJNAstraZeneca to Buy Icosavax for Up to $1.1 Billion -- Update
12/12/202302:47DJNAstraZeneca to Buy Icosavax for Up to $1.1 Billion
12/12/202302:05GLOBEIcosavax, Inc. Announces Agreement to be Acquired by..
12/12/202302:00GLOBEIcosavax Announces Positive Topline Interim Phase 2 Results..
11/14/202316:05GLOBEIcosavax Reports Third Quarter 2023 Financial Results and..
11/08/202308:00GLOBEIcosavax to Participate in the Jefferies London Healthcare..
10/31/202308:00GLOBEIcosavax to Participate in the Guggenheim Healthcare Talks..

Your Recent History

Delayed Upgrade Clock